Dubai Hospital is a 625-bed general medical/surgical hospital in Dubai, the United Arab Emirates, and is part of Dubai Department of Health and Medical Services.Although the decision to construct Dubai Hospital was made in 1977, it did not begin admitting patients until March, 1983.The hospital consists of 14 stories, with the lower two for Accident & Emergency and outpatients, and the upper ten for wards..
Idiopathic sudden sensorineural hearing loss (ISSNHL) is traditionally managed as a uniform clinical emergency using empirical corticosteroid protocols, yet outcomes vary widely, suggesting underlying etiologic heterogeneity. This review aims to propose a precision medicine framework for ISSNHL by re-examining the condition through specific pathophysiologic determinants, including structural third window syndromes, microvascular compromise, and metabolic factors. A narrative synthesis of emerging evidence regarding 3D-FLAIR MRI, high-resolution CT (HRCT), and metabolic profiling is presented. Illustrative cases of Enlarged Vestibular Aqueduct (EVA) and Superior Semicircular Canal Dehiscence (SSCD) are utilized to highlight the limitations of traditional steroid therapy in structural phenotypes. A significant proportion of “idiopathic” cases can be stratified into distinct pathophysiologic phenotypes. Structural anomalies (TWS) often exhibit limited steroid responsiveness but benefit from early biomechanical identification. Furthermore, advanced imaging like 3D-FLAIR MRI reveals blood-labyrinth barrier (BLB) disruption as a prognostic marker for vascular-driven hearing loss. Metabolic factors, such as Vitamin D and B12 deficiencies, further modulate cochlear resilience and recovery potential. SSNHL should be managed as a heterogeneous syndrome. We propose a stratified management algorithm that integrates high-resolution imaging and metabolic screening into early decision-making. Shifting toward pathophysiology-guided care allows for personalized adjuvant strategies (e.g., HBOT, metabolic correction) and more accurate prognostic counseling, ultimately improving individualized patient outcomes.
We used Delphi methodology to provide guidance on gender equality and equity issues in professional life in intensive care, where information is evolving and no clear standard exists. A 12-member Steering Committee (7 women, 5 men) from 7 countries and 46 international panelists [(23 women, 21 men, 2 preferred not to disclose; median age 52 (33–75) years] from 32 countries (43
Obesity is a chronic, debilitating condition with complex biological, psychosocial, and behavioral underpinnings. While the cardiometabolic consequences are reasonably well-established, the often-forgotten bidirectional association between obesity and mental health disorders, including anxiety, eating disorders, depression, and even suicidal ideations, is rarely assessed as a primary endpoint in obesity intervention studies. Similarly, documents summarizing and comparing various types of obesity interventions and their effects of mental health in this rapidly evolving field are scarce. This narrative review synthesizes the evidence on the psychological impact of lifestyle, pharmacological, and surgical interventions in the treatment of obesity. Special focus is placed on glucagon-like peptide-1 (GLP-1) receptor agonists, given their rising global use and emerging concerns regarding mental health safety. A thorough literature review was conducted across the MEDLINE, Embase, and Cochrane databases, focusing on meta-analyses, systematic reviews, and clinical trials published up to June 2025. Studies examining psychological outcomes in patients undergoing lifestyle modifications, pharmacotherapy, or bariatric surgery for weight loss were included. Mental health domains considered included quality of life, anxiety, depression, and suicidality. Due to the vast array of obesity interventions and the broad nature of mental health in the literature, this review was conducted to provide a narrative summary. Behavioral interventions consistently showed no harm to mental health and demonstrated modest improvements in depression and mental health-related quality of life. Bariatric surgery was associated with short-to-medium-term reductions in depressive and anxiety symptoms, though long-term benefits were attenuated, with some studies reporting increased suicidality after five years. Pharmacotherapies, including orlistat, bupropion/naltrexone, and phentermine/topiramate, showed mixed psychiatric impacts. The GLP-1 receptor agonists (Semaglutide, liraglutide, Tirzepatide) have shown an improvement in patient-reported mental wellbeing in several trials. Concerningly, pharmacovigilance data initially suggested a possible link with suicidality; however, subsequent robust cohort studies and meta-analyses have refuted this association. Mental health is a critical yet underprioritized element of obesity management. The current evidence suggests that most weight loss interventions are psychologically safe or beneficial, but long-term data remain limited, particularly for GLP-1 receptor agonists. Future randomized trials must incorporate mental health as a prespecified outcome, and individualized treatment approaches should integrate psychological support to optimize long-term outcomes. This review has summarized, side-by-side, the various outcomes of obesity interventions on mental health.
Introduction: Fibrohistiocytomas are uncommon mesenchymal tumors that typically originate in the dermis or subcutaneous tissue, and are rarely reported in deeper locations, such as bone, retroperitoneum, or the head and neck. Primary thyroid involvement is exceedingly rare, with only sporadic reports of benign and malignant variants. Papillary thyroid carcinoma (PTC) is the most prevalent thyroid malignancy, characterized by distinct nuclear features and well-established cytological criteria. The coexistence of PTC with fibrohistiocytoma within the thyroid region has not been previously described. We report a case of synchronous PTC and fibrohistocytoma, highlighting the diagnostic challenges posed by overlapping clinical and radiological features and underscoring the role of histopathology in guiding management. Case report ; A 52-year-old Asian male patient presented to our clinic with a history of massive neck swelling with a central open wound present for the past 2 months and now increasing in size. The swelling occupied almost the entire neck, and the neck nodes and thyroid gland were not palpable due to the presence of swelling. Further workup showed a suspicious thyroid nodule and neck swelling, which was attributable to metastatic lymph nodes. The thyroid nodule was biopsied and showed papillary thyroid cancer. The case was discussed in a multidisciplinary team meeting, and it was decided to proceed with total thyroidectomy with modified bilateral neck dissection. Histopathology showed two different pathologies: papillary thyroid cancer PT1b and a lateral neck mass. Histopathology of the lateral neck mass revealed fibrohistiocytoma. Conclusion: The case highlights the diagnostic challenges that arise when such tumors are present concomitantly. Lateral neck mass was attributed to be metastatic papillary thyroid cancer rather than a separate pathology, and no pre op biopsy of the mass was taken. When there is a discrepancy between the size of the primary tumor (in our case, a small thyroid papillary tumor) and the metastatic deposit (a large neck mass attributed to metastatic papillary thyroid cancer), separate biopsies should be taken from both regions to confirm the diagnosis. A multidisciplinary approach should be employed to manage this case.
